Aragen, a global contract research, development and manufacturing organization, has secured a $100 million investment from Quadria Capital, an Asia healthcare-focused Private Equity fund. Quadria acquires a minority stake in Aragen at an approximate valuation of $1.4 billion. This funding will support Aragen’s strategic expansion of its capabilities and infrastructure to support growing demand for outsourcing services from innovators in the U.S. and Europe. “We are delighted to welcome Qua...